Gynecology department pelvic floor cold application plaster used for postnatal vulva detumescence and analgesia
A gynecological and vulvar technology, applied in the directions of extracellular fluid diseases, non-central analgesics, medical preparations with non-active ingredients, etc. , to avoid perineal pain, reduce liver and kidney toxicity, and avoid first-pass effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0025] The gel layer used in this experiment contains the following mass percentage compositions: The gel layer contains the following mass percentage compositions: 0.1% hyaluronic acid, 0.25% glycerin, 0.2% ethylparaben, 0.2% % carbomer, 0.25% poloxamer, 0.75% pH regulator, 5.5% hazelnut extract, 3.5% angelica extract, 0.1% medical zinc oxide, 0.9% peppermint Brain and cooling agent, the rest is purified water.
[0026] In this example, hyaluronic acid can provide a better water environment while promoting collagen growth; herbal extracts can provide a better microenvironment and supplement nutrients.
Embodiment 2
[0028] On the basis of the ratio of the above ingredients, the inventor also believes that other auxiliary ingredients can be added to the hyaluronic acid dressing, so in this embodiment, a space for adding other auxiliary ingredients is reserved in the above ingredients, specifically In terms of mass percentage: 0.4% hyaluronic acid, 0.2% glycerin, 0.1% ethylparaben, 0.2% carbomer, 0.25% poloxamer, 0.75% pH regulator, Shanze Orchid extract 5%, Angelica extract 5%, 77.2% water, 10.0% other auxiliary ingredients.
[0029] In this example, the gel layer prepared by using the above-mentioned proportions in the experiment basically continued the effect of Example 1, and the therapeutic effect could be superimposed according to the added auxiliary ingredients other than the above-mentioned ingredients; but it needs to be explained Yes, the above-mentioned 10.0% other auxiliary ingredients should be substances with mild chemical properties, which cannot conflict with the chemical pr...
Embodiment 3
[0031] A total of 400 cases of vaginal delivery women who were admitted to the obstetrics department of the cooperative hospital from June 2014 to June 2018 were selected, and none of them received epidural analgesia. According to the random number table method, they were divided into treatment group and control group, with 200 cases in each group. All patients in the two groups were primiparous, and the newborns and maternal patients were healthy, without pregnancy complications, and without breastfeeding contraindications. There was no significant difference between the two groups in clinical data such as age and gestational week (all P>0.05), which were comparable.
[0032] The treatment group applied the cold compress obtained in Example 1 of the present invention, and the puerpera used it for the first time after the delivery debridement was clean, 15 minutes / time, 2 times / d, and the treatment ended when she was discharged from the hospital within 48 hours.
[0033] Patie...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com